Date Title Description PDF
07 Nov 2024 On P&L The Company releases the press release related to the first nine months 2024 financial results Download
07 Nov 2024 On P&L The Company releases the first nine months 2024 financial results presentation Download
24 Oct 2024 On corporate transactions ROVI completes the strategic review of its CDMO business Download
31 Jul 2024 On P&L The Company releases the press release related to the first half 2024 financial results Download
31 Jul 2024 On P&L The Company releases the first half 2024 financial results presentation Download

Pages

Date Title Description PDF
12 Mar 2024 On business and financial situation ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies Download
08 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 March and 7 March 2024 Download
07 Mar 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives  Download
01 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 23 February and 29 February 2024 Download
27 Feb 2024 Annual Financial Reports and Audit Reports The Company submits the 2023 Annual Financial Report  Download

Pages

Date Title Description PDF
16 Feb 2017 Información sobre resultados (2) ROVI releases the press release related to the full year 2016 results Download
16 Feb 2017 Información sobre resultados ROVI releases the presentation related to the full year 2016 results Download
16 Feb 2017 Informe Anual de Gobierno Corporativo ROVI releases the 2016 Annual Corporate Governance Report Download
10 Jan 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the fourth quarter of 2016 Download
22 Nov 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Neparvis in Spain Download

Pages